The Maimi Project to Cure Paralysis
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ibrahim, Emad
HLX10-020-SCLC302, NCT05353257 / 2022-002226-27: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Active, not recruiting
3
511
Europe, US, RoW
HLX10, Serplulimab, carboplatin/cisplatin-etoposide, Thoracic radiotherapy, Placebo, Prophylactic Cranial Irradiation (PCI)
Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc.
Limited-Stage Small Cell Lung Cancer
07/25
12/26
PRESERVE-003, NCT05671510: ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Active, not recruiting
3
600
Europe, Canada, US, RoW
Gotistobart, A humanized anti-CTLA4 IgG1 monoclonal antibody, ONC-392, BNT316, Docetaxel, Docefrez, Taxotere
OncoC4, Inc., BioNTech SE
Non Small Cell Lung Cancer
06/26
06/27
NCT05903859: Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)

Recruiting
3
90
US
Probenecid 500 Milligrams (mg), probenecid 250 Milligrams (mg), Placebo
University of Miami, United States Department of Defense
Infertility, Male
05/27
12/28
NCT05800015: A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Recruiting
2/3
950
Canada, US, RoW
fianlimab, REGN3767, cemiplimab, REGN2810, Libtayo, Pemetrexed, Alimta, Paclitaxel, Carboplatin, Paraplatin, Cisplatin, Platinol, Placebo
Regeneron Pharmaceuticals
Non-small Cell Lung Cancer
01/30
12/31
R3767-ONC-2235, NCT05785767: A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Hourglass Nov 2024 - Dec 2024 : Initial data from trial in combination with Libtayo for advanced NSCLC
Recruiting
2/3
850
Canada, US, RoW
fianlimab, REGN3767, cemiplimab, REGN2810, Libtayo, Placebo
Regeneron Pharmaceuticals
Advanced Non-Small Cell Lung Cancer
03/30
02/32
COCKTAIL, NCT05048667: Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction

Active, not recruiting
1
60
US
Shock Wave therapy (SWT), Platelet Rich Plasma (PRP), Sham SWT, Placebo Saline
University of Miami, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Erectile Dysfunction
01/25
01/25
NCT04382209: The Goal of This Study is to Evaluate the Effect of Ultrasound Guided Erector Spinae Plane Block on Postoperative Pain After Major Abdominal Surgeries

Active, not recruiting
N/A
56
RoW
Erector spinae plane block, Intravenous meperidine patient controlled analgesia device
Suez Canal University
Postoperative Pain
09/20
09/20
SOAB, NCT04146922: Switch to Oral Antibiotics in Gram-negative Bacteremia

Completed
N/A
176
RoW
Step down to oral antimicrobial therapy, IV antimicrobial therapy
Hamad Medical Corporation
Escherichia Coli Bacteremia, Klebsiella Bacteraemia, Enterobacter Bacteraemia, Serratia Bacteraemia, Citrobacter Bacteraemia, Proteus Bacteraemia
08/22
07/23
NCT01467869: Male Fertility Program

Recruiting
N/A
100
US
University of Miami
Spinal Cord Injury
12/35
12/40

Download Options